ICON plc has acquired the Mapi Group, a Patient-Centered Health Outcomes Research and Commercialisation company. The acquisition expands ICON’s Commercialization and Outcomes Research business adding significant commercialization presence, analytics, real world evidence generation and strategic regulatory expertise. The acquisition also provides direct access to Mapi Research Trust, a library of Clinical Outcomes Assessments (COAs), with exclusive distribution of over 300 families of validate...